The risk profile of electronic nicotine delivery systems, compared to traditional cigarettes, on oral disease: a review

被引:3
|
作者
Zhang, Qing [1 ]
Wen, Cai [2 ,3 ,4 ,5 ]
机构
[1] Southwest Med Univ, Dept Nosocomial Infect Control, Affiliated Hosp, Luzhou, Sichuan, Peoples R China
[2] Southwest Med Univ, Dept Oral Implantol, Affiliated Stomatol Hosp, Luzhou, Sichuan, Peoples R China
[3] Southwest Med Univ, Dept VIP Dent Serv, Affiliated Stomatol Hosp, Luzhou, Sichuan, Peoples R China
[4] Southwest Med Univ, Luzhou Key Lab Oral & Maxillofacial Reconstruct &, Affiliated Stomatol Hosp, Luzhou, Sichuan, Peoples R China
[5] Southwest Med Univ, Inst Stomatol, Luzhou, Sichuan, Peoples R China
关键词
electronic nicotine delivery systems; tobacco; oral disease; e-cigarette; stomatology; TOBACCO-SPECIFIC NITROSAMINES; EXPOSURE; PRODUCTS; CARCINOGEN; SMOKING; USERS;
D O I
10.3389/fpubh.2023.1146949
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The use of electronic nicotine delivery systems (ENDS) has exploded, especially among teenagers and new smokers, amid widespread awareness of the dangers of traditional tobacco and restrictions on smoking. However, the risk effects of ENDS on physical health, especially oral health, are still ambiguous. The purpose of this study was to review the available evidence on risks of ENDS on oral health, and compares the differences between ENDS and traditional cigarettes. For heavy smokers, transferring the addiction of tobacco to ENDS can be less harmful to periodontal condition and physical health but is not completely without risk. The components of ENDS vapor have cytotoxic, genotoxic, and carcinogenic properties, and its usage may be associated with a wide range of oral health sequelae. The chemicals in ENDS increase the susceptibility to tooth decay, increase the risk of periodontal disease, peri-implant, and oral mucosal lesions. Nicotine aerosols from ENDS can be a potential risk factor for oral cancer due to the presence of carcinogenic components. Compared to smoking traditional cigarettes, the harm associated with ENDS use may be underestimated due to the reduced ability to control vaping behavior, ease of ENDS access, fewer vaping area restrictions, and better taste. Currently, the available evidence suggests that ENDS may be a safer alternative to traditional tobacco products. Though most oral symptoms experienced by ENDS users are relatively mild and temporary compared to traditional cigarettes, the dangers of ENDS still exist. However, further research with longer follow-up periods is required to establish the long-term safety of ENDS.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Comparison of brain nicotine accumulation from traditional combustible cigarettes and electronic cigarettes with different formulations
    Zuo, Yantao
    Sai, Kiran Kumar Solingapuram
    Jazic, Aeva
    Bansode, Avinash H.
    Rose, Jed E.
    Mukhin, Alexey G.
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 (04) : 740 - 746
  • [42] Nicotine forms: why and how do they matter in nicotine delivery from electronic cigarettes?
    Gholap, Vinit V.
    Kosmider, Leon
    Golshahi, Laleh
    Halquist, Matthew S.
    EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (12) : 1727 - 1736
  • [43] Prevalence of electronic nicotine delivery systems and electronic non-nicotine delivery systems in children and adolescents: a systematic review and meta-analysis
    Yoong, Sze Lin
    Hall, Alix
    Leonard, Alecia
    McCrabb, Sam
    Wiggers, John
    d'Espaignet, Edouard Tursan
    Stockings, Emily
    Gouda, Hebe
    Fayokun, Ranti
    Commar, Alison
    Prasad, Vinayak M.
    Paul, Christine
    Oldmeadow, Christopher
    Chai, Li Kheng
    Thompson, Bruce
    Wolfenden, Luke
    LANCET PUBLIC HEALTH, 2021, 6 (09): : E661 - E673
  • [44] A Clinical Laboratory Model for Evaluating the Acute Effects of Electronic "Cigarettes": Nicotine Delivery Profile and Cardiovascular and Subjective Effects
    Vansickel, Andrea R.
    Cobb, Caroline O.
    Weaver, Michael F.
    Eissenberg, Thomas E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (08) : 1945 - 1953
  • [45] Clinical pharmacology of nicotine in electronic nicotine delivery systems
    Peruga, Armando
    Eissenberg, Thomas
    WHO STUDY GROUP ON TOBACCO PRODUCT REGULATION: REPORT ON THE SCIENTIFIC BASIS OF TOBACCO PRODUCT REGULATION: SEVENTH REPORT OF A WHO STUDY GROUP, 2019, 1015 : 31 - 74
  • [46] Commentary: Electronic Nicotine Delivery Systems
    Sissung, Tristan M.
    Figg, William D.
    FAMILY & COMMUNITY HEALTH, 2022, 45 (03) : 202 - 205
  • [47] Use and Risk Perception of Electronic Nicotine Delivery Systems and Tobacco in Pregnancy
    Bhandari, Naleen Raj
    Day, Kanesha D.
    Payakachat, Nalin
    Franks, Amy M.
    McCain, Keith R.
    Ragland, Denise
    WOMENS HEALTH ISSUES, 2018, 28 (03) : 251 - 257
  • [48] Electronic nicotine delivery systems and/or electronic non-nicotine delivery systems for tobacco smoking cessation or reduction: a systematic review and meta-analysis
    El Dib, Regina
    Suzumura, Erica A.
    Akl, Elie A.
    Gomaa, Huda
    Agarwal, Arnav
    Chang, Yaping
    Prasad, Manya
    Ashoorion, Vahid
    Heels-Ansdell, Diane
    Maziak, Wasim
    Guyatt, Gordon
    BMJ OPEN, 2017, 7 (02):
  • [49] Effects of Combustible Cigarettes and Electronic Nicotine Delivery Systems on the Development and Progression of Chronic Lung Inflammation in Mice
    Kastratovic, Nikolina
    Markovic, Vladimir
    Harrell, Carl Randall
    Arsenijevic, Aleksandar
    Stojanovic, Milica Dimitrijevic
    Djonov, Valentin
    Volarevic, Vladislav
    NICOTINE & TOBACCO RESEARCH, 2024, 26 (06) : 704 - 714
  • [50] Modeling drug exposure in rodents using e-cigarettes and other electronic nicotine delivery systems
    Miliano, Cristina
    Scott, E. Reilly
    Murdaugh, Laura B.
    Gnatowski, Emma R.
    Faunce, Christine L.
    Anderson, Megan S.
    Reyes, Malissa M.
    Gregus, Ann M.
    Buczynski, Matthew W.
    JOURNAL OF NEUROSCIENCE METHODS, 2020, 330